Nat Clin Pract Cardiovasc Med. 2006;3(7):346-347. Since the first widespread clinical application of left ventricular assist devices (LVADs) for patients with end-stage heart failure in the late 1980s ...

Medicare beneficiaries with heart failure who are Black or female were less likely to receive a left ventricular assist device (LVAD) implantation compared with White and male beneficiaries. Between ...

Fineheart SA will soon begin a first-in-human study of Flowmaker, its fully implantable left ventricular assist device, in France, after receiving authorization from the French National Agency for the ...

IIIF provides researchers rich metadata and media viewing options for comparison of works across cultural heritage collections. Visit the IIIF page to learn more. The HeartMate II Left Ventricular ...

The Cardiovascular Surgery Group at Osaka University succeeded in minimally invasive treatment of a patient with acute heart failure due to medical treatment-resistant cardiogenic shock by making use ...

A multi-institution research effort led by Harvard Medical School, Boston, has looked into the safety and efficacy of excluding aspirin from the treatment of patients with advanced heart failure ...

PHILADELPHIA (WPVI) -- Ten years is a significant milestone in any relationship. But it is especially monumental for one man and the medical device that helps keep him alive. Vince McCormack is one of ...

There is no clearly established strategy for the treatment of a patient with cardiomyopathy and a symptomatic aneurysm of the thoracic aorta. We report the successful use of an approach combining ...

Right ventricular (RV) failure is a major cause of morbidity and mortality in patients who have undergone surgical implantation of a left ventricular assist device (LVAD); therefore, it is important ...

Connex Biomedical Inc. applied for patent protection for a transcardiac access port affixed and retained post-procedure on the cardiac muscle, such as the ventricular myocardium, and an access port ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...